Quick Answer
CHEMED CORP reported Operating Income Loss of $338.25 million for the year ending 2025.
- CHEMED CORP showed a decrease of -7.7% in Operating Income Loss from 2024 to 2025.
- This data is from CHEMED CORP's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), CHEMED CORP's Operating Income Loss has grown by 154.6%.
- Historical annual values: Fiscal year 2025: $338.25 million | Fiscal year 2024: $366.49 million | Fiscal year 2023: $340.57 million | Fiscal year 2022: $343.50 million | Fiscal year 2021: $343.04 million | Fiscal year 2020: $389.68 million | Fiscal year 2019: $257.38 million | Fiscal year 2018: $243.63 million | Fiscal year 2017: $113.04 million | Fiscal year 2016: $178.75 million | Fiscal year 2015: $184.46 million | Fiscal year 2014: $168.42 million | Fiscal year 2013: $133.39 million | Fiscal year 2012: $156.42 million | Fiscal year 2011: $153.73 million | Fiscal year 2010: $143.52 million | Fiscal year 2009: $126.35 million | Fiscal year 2008: $132.86 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: